Ειδήσεις: TARGET | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 18:16 yahoo.com

Citi Cuts PT on Stellantis N.V. (STLA) to EUR 7 From EUR 8 – Here’s Why

Citi Stellantis price target electric vehicles auto industry earnings outlook

31/03 18:06 yahoo.com

JPMorgan Cuts PT on Zai Lab Limited (ZLAB) to $32 From $39 – Here’s Why

Zai Lab JPMorgan price target cut earnings outlook regulatory hurdles market competition

31/03 18:06 yahoo.com

RBC Capital Cuts PT on Legend Biotech Corporation (LEGN) to $62 From $66 – Here’s Why

RBC Capital Legend Biotech price target earnings valuation regulatory approvals

31/03 18:06 yahoo.com

Jefferies Lifts PT on Lantheus Holdings (LNTH) to $110 From $105 – Here’s Why

Jefferies Lantheus Holdings price target earnings outlook pipeline revenue growth

31/03 18:06 yahoo.com

Wells Fargo Lifts PT on Liquidia Corporation (LQDA) to $51 From $44 – Here’s Why

Wells Fargo Liquidia price target biotech earnings outlook product pipeline

31/03 18:06 yahoo.com

Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 – Here’s Why

Cantor Fitzgerald Apellis Pharmaceuticals price target drug pipeline regulatory hurdles financial outlook

31/03 18:06 yahoo.com

Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 – Here’s Why

BridgeBio Pharma Mizuho price target pipeline positive trial data strategic partnerships

31/03 18:06 yahoo.com

Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why

Insmed Stifel price target earnings outlook pipeline stock upgrade

31/03 18:06 yahoo.com

BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why

BioNTech BMO Capital price target vaccine demand earnings outlook competition

31/03 18:06 yahoo.com

BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why

BioNTech BMO Capital price target vaccine demand earnings outlook competition

Loading...